20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
As the fall-out from COVID-19 threatens to sink entire portfolios, PE sponsors and CEO’s need to walk a tightrope between preserving organisational capabilities in order to resume growth in case of a rebound in 2H 2020, while at the same time preparing to survive a protracted recession or even depression if things go wrong.
Our latest HumaticaCorner explores the options for portfolio managers and CEOs.
The evidence that AI improves individual productivity is now overwhelming. Across dozens of controlled studies, knowledge workers with AI tools consistently outperform those without —…
Read more
Every significant technological shift in economic history has ultimately changed the shape of organisations — not just the tools they use, but their structures, hierarchies,…
Read more
This is the final article in a three-part series on designing and implementing a fit-for-purpose Target Operating Model. In Part I, we explored how to…
Read more
Receive our news and valuable perspectives on organizational effectiveness each month.
